Vaccination in the elderly: an immunological perspective.
暂无分享,去创建一个
Beatrix Grubeck-Loebenstein | R. Effros | R. Edelman | Wilbur H. Chen | M. Sztein | B. Grubeck‐Loebenstein | Robert Edelman | Bernard Kozlovsky | Rita B Effros | Wilbur H Chen | Bernard F Kozlovsky | Marcelo B Sztein
[1] R. Kumar,et al. Age-related decline in immunity: implications for vaccine responsiveness , 2008, Expert review of vaccines.
[2] K. Nichol,et al. Immune function and vaccine responses in healthy advanced elderly patients. , 2000, Archives of internal medicine.
[3] R. Effros. Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly. , 1998, American journal of human genetics.
[4] N. Gualde,et al. Hepatitis-B vaccination in the elderly. , 1984, The Journal of infectious diseases.
[5] E. van der Velde,et al. Correlation between the antibody response to influenza vaccine and helper T cell subsets in healthy aging. , 1996, Vaccine.
[6] Onchee Yu,et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. , 2003, The New England journal of medicine.
[7] Cecile Viboud,et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.
[8] C. Franceschi,et al. The immune system in extreme longevity , 2008, Experimental Gerontology.
[9] S. Gravenstein,et al. Granzyme B: a marker of risk for influenza in institutionalized older adults. , 2001, Vaccine.
[10] J. Myśliwska,et al. Immunomodulating effect of influenza vaccination in the elderly differing in health status , 2004, Experimental Gerontology.
[11] M. Clements,et al. Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens. , 1994, The Journal of infectious diseases.
[12] A. Kumar. Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults , 2006 .
[13] R. Belshe,et al. Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and "original antigenic sin". , 1994, The Journal of infectious diseases.
[14] S. Halperin,et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] S. Halperin,et al. Morbidity of pertussis in adolescents and adults. , 2000, The Journal of infectious diseases.
[16] D N Posnett,et al. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy" [published erratum appears in J Exp Med 1994 Mar 1;179(3):1077] , 1994, The Journal of experimental medicine.
[17] G. Pawelec,et al. From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly , 2009, Biogerontology.
[18] H. Müller-Hermelink,et al. Admission criteria for immunogerontological studies in man: The senieur protocol , 1984, Mechanisms of Ageing and Development.
[19] C. Harley,et al. Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes1 , 2008, The Journal of Immunology.
[20] K. Pfeiffer,et al. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. , 2005, Vaccine.
[21] C. Harley,et al. Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. , 1996, AIDS.
[22] C. Vitek,et al. Diphtheria in the Russian Federation in the 1990s. , 2000, The Journal of infectious diseases.
[23] K. Nichol,et al. Effectiveness of influenza vaccine in the community-dwelling elderly. , 2007, The New England journal of medicine.
[24] Trang Vu,et al. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. , 2002, Vaccine.
[25] P. Kourilsky,et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. , 1997, Journal of immunology.
[26] Mark A. Miller,et al. Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. , 2006, Vaccine.
[27] J. Blumberg,et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. , 1997, JAMA.
[28] C. Ewen,et al. T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly1 , 2006, The Journal of Immunology.
[29] R. Seufert,et al. CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7 , 2002, Zentralblatt fur Gynakologie.
[30] G. Pawelec,et al. Large Numbers of Dysfunctional CD8+ T Lymphocytes Bearing Receptors for a Single Dominant CMV Epitope in the Very Old , 2003, Journal of Clinical Immunology.
[31] J. Norris,et al. Letter: G.A.B.A. in Huntington's chorea. , 1974, Lancet.
[32] D. Fedson,et al. Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults. , 2004, Vaccine.
[33] K. Leder,et al. Travel vaccines and elderly persons: review of vaccines available in the United States. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] D. Jenkinson. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study , 1988, British medical journal.
[35] Ping Li,et al. Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age. , 2009, Vaccine.
[36] N. Gualde,et al. Alterations in the human immune response to the hepatitis B vaccine among the elderly. , 1987, Cellular immunology.
[37] W. Bancroft,et al. Immunogenicity of an inactivated hepatitis A vaccine. , 1991, Annals of internal medicine.
[38] S. de Rave,et al. Immunogenicity of standard and low dose vaccination using yeast-derived recombinant hepatitis B surface antigen in elderly volunteers. , 1994, Vaccine.
[39] V. Valcour,et al. Tetanus Immunity in Long‐Term Care Facilities , 2003, Journal of the American Geriatrics Society.
[40] B. Thiers. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults , 2006 .
[41] A. Razmpour,et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[42] E. Schiff,et al. Immunogenicity of two recombinant hepatitis B vaccines in older individuals. , 1993, The American journal of medicine.
[43] J. Hadler,et al. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. , 1993, JAMA.
[44] G. Pawelec,et al. Is immunosenescence infectious? , 2004, Trends in immunology.
[45] Tom Jefferson,et al. Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.
[46] K. Pfeiffer,et al. Circulating cytotoxic CD8+ CD28- T cells in ankylosing spondylitis , 2001, Arthritis research.
[47] K. Alagappan,et al. Antibody protection to diphtheria in geriatric patients: need for ED compliance with immunization guidelines. , 1997, Annals of emergency medicine.
[48] G. Fara,et al. Immune response of the elderly to rabies vaccines. , 1994, Vaccine.
[49] P. Gergen,et al. A population-based serologic survey of immunity to tetanus in the United States. , 1995, The New England journal of medicine.
[50] G. Schiffman,et al. Impaired Antibody Responses to Pneumococcal Polysaccharide in Elderly Patients with Low Serum Vitamin B12 Levels , 1996, Annals of Internal Medicine.
[51] E. Hoster,et al. Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. , 2006, Vaccine.
[52] R. Effros. Replicative senescence: the final stage of memory T cell differentiation? , 2003, Current HIV research.
[53] T. Ceddia,et al. Antibody response to rabies vaccine prepared in tissue cultures of human diploid cells and inactivated, evaluated in different classes of age. , 1982, Annali Sclavo; rivista di microbiologia e di immunologia.
[54] D. Knook,et al. Necessity of the assessment of health status in human immunogerontological studies: Evaluation of the senieur protocol , 1990, Mechanisms of Ageing and Development.
[55] R. Effros,et al. Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation☆ , 1999, Experimental Gerontology.
[56] K. Pillay. Congenital Hypothyroidism and Immunodeficiency: Evidence for an Endocrine-Immune Interaction , 1998, Journal of pediatric endocrinology & metabolism : JPEM.
[57] Silvia Maggini,et al. Contribution of Selected Vitamins and Trace Elements to Immune Function , 2007, Annals of Nutrition and Metabolism.
[58] A. Detsky,et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. , 1994, Archives of internal medicine.
[59] K. Leder,et al. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] R. Edelman,et al. Clinical evaluation of adjuvants , 2006 .
[61] Cecile Viboud,et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. , 2007, The Lancet. Infectious diseases.
[62] D. Knook,et al. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. , 1999, The Journal of infectious diseases.
[63] S. Gravenstein,et al. Efficacy of an Influenza Hemagglutinin‐Diphtheria Toxoid Conjugate Vaccine in Elderly Nursing Home Subjects During an Influenza Outbreak , 1994, Journal of the American Geriatrics Society.
[64] Mark M Davis,et al. A prescription for human immunology. , 2008, Immunity.
[65] M. Katsurada,et al. A field trial with an improved Japanese encephalitis vaccine in a nonendemic area of the disease. , 1970, Biken journal.
[66] W. O'Fallon,et al. Value of Immunological Markers in Predicting Responsiveness to Influenza Vaccination in Elderly Individuals , 2001, Journal of Virology.
[67] R. Detels,et al. Premature Aging of T cells Is Associated With Faster HIV-1 Disease Progression , 2009, Journal of acquired immune deficiency syndromes.
[68] C. Franceschi,et al. Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects1 , 2007, The Journal of Immunology.
[69] S. Castle,et al. Clinical relevance of age-related immune dysfunction. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[70] S. le Cessie,et al. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. , 1997, Vaccine.
[71] C. Franceschi,et al. Cytomegalovirus Infection , 2007, Annals of the New York Academy of Sciences.
[72] G. Pawelec,et al. Compromised interferon gamma (IFN-gamma) production in the elderly to both acute and latent viral antigen stimulation: contribution to the immune risk phenotype? , 2002, European cytokine network.
[73] G. Leroux-Roels,et al. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. , 2008, Vaccine.
[74] E. Yunis,et al. The immune response to hepatitis B vaccine in humans: inheritance patterns in families , 1992, The Journal of experimental medicine.
[75] E. Gardner,et al. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly , 2002, Experimental Gerontology.
[76] D. Skowronski,et al. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? , 2008, The Journal of infectious diseases.
[77] P. Gregersen,et al. Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset. , 1995, Journal of immunology.
[78] V. Schijns. Immunopotentiators in modern vaccines , 2003 .
[79] R. Breiman,et al. Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .
[80] G. Carlone,et al. Elderly immune response to a TI-2 antigen: heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide. , 1999, The Journal of infectious diseases.
[81] V Demicheli,et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review , 2005, The Lancet.
[82] H. Sacks,et al. The Efficacy of Influenza Vaccine in Elderly Persons , 1995, Annals of Internal Medicine.
[83] P. Peduzzi,et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. , 2005, The New England journal of medicine.
[84] E. Barnett. Yellow fever: epidemiology and prevention. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[85] G. Ligthart,et al. Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay , 1998, Journal of medical virology.
[86] D. Frasca,et al. Heterogeneity of immune responsiveness in healthy elderly subjects. , 1988, Clinical immunology and immunopathology.
[87] C. Llor,et al. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[88] M. L. Clements-Mann,et al. Immunogenicity of two doses of yeast recombinant hepatitis B vaccine in healthy older adults. , 1997, The Journal of infectious diseases.
[89] R. Tampi,et al. Valproic Acid-Induced Hyperammonemia in the Elderly: A Review of the Literature , 2009, Case reports in medicine.
[90] J. Myśliwska,et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. , 2003, Vaccine.
[91] D. Breuillé,et al. The inflammatory response to vaccination is altered in the elderly , 2005, Mechanisms of Ageing and Development.
[92] Malbea A Lapete,et al. Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2004 .
[93] G. Pawelec,et al. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? , 1997, Immunology today.
[94] C. Alper. The human immune response to hepatitis B surface antigen. , 1995, Experimental and clinical immunogenetics.
[95] F. Fabrizi,et al. Meta‐analysis: the effect of age on immunological response to hepatitis B vaccine in end‐stage renal disease , 2004, Alimentary pharmacology & therapeutics.
[96] R. Edelman,et al. Mechanisms of defective delayed cutaneous hypersensitivity in children with protein-calorie malnutrition. , 1973, Lancet.
[97] S. Hadler,et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. , 1989, Vaccine.
[98] B. Grubeck‐Loebenstein,et al. [Immune reaction to tetanus in the elderly: what is the duration of vaccine protection?]. , 1997, Wiener klinische Wochenschrift.
[99] P. Galan,et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. , 1999, Archives of internal medicine.
[100] C. Bellak,et al. Hepatitis A vaccination. , 1998, The New England journal of medicine.
[101] A. Amadori,et al. Quantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Humoral immune response enhancement by thymostimulin. , 1993, Vaccine.
[102] Sandra Romero-Steiner,et al. Use of Opsonophagocytosis for Serological Evaluation of Pneumococcal Vaccines , 2006, Clinical and Vaccine Immunology.
[103] R. Ciubotariu,et al. CD8+CD28− T suppressor cells and the induction of antigen‐specific, antigen‐presenting cell‐mediated suppression of Th reactivity , 2001, Immunological reviews.
[104] Cécile Viboud,et al. Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.
[105] E. Gardner,et al. Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. , 2006, Vaccine.
[106] B. Grubeck‐Loebenstein,et al. No immunity for the elderly , 1998, Nature Medicine.
[107] C. Franceschi,et al. Centenarians as a model for healthy aging. , 2003, Biochemical Society transactions.
[108] C. Kallenberg,et al. Influence of ageing on antibody formation in vivo after immunisation with the primary T-cell dependent antigen Helix pomatia haemocyanin , 1992, Mechanisms of Ageing and Development.
[109] Walther Parson,et al. Lack of Antibody Production Following Immunization in Old Age: Association with CD8+CD28− T Cell Clonal Expansions and an Imbalance in the Production of Th1 and Th2 Cytokines1 , 2002, The Journal of Immunology.
[110] Robert T. Chen,et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. , 2005, Vaccine.
[111] K. High. Immunizations in older adults. , 2007, Clinics in geriatric medicine.
[112] R. Effros,et al. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. , 2002, Clinical immunology.
[113] T. Whiteside,et al. Rapid turnover of the CD8+CD28- T-cell subset of effector cells in the circulation of patients with head and neck cancer , 2003, Cancer Immunology, Immunotherapy.